Related Experiment Video
Updated: Jun 10, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Subclinical Myocardial Fibrosis in South African Youth With HIV: Results From the CTAAC-Heart Study
Jennifer Jao1, Heather J Zar2, Morné Kahts3,4
1Division of Pediatric Infectious Diseases, Division of Adult Infectious Diseases, Department of Pediatrics, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Insights
Youth with HIV on antiretroviral therapy show increased subclinical myocardial fibrosis. This highlights the need for early cardiovascular disease screening and monitoring in this population.
Area of Science:
- Cardiology
- Infectious Diseases
- Pediatrics
Background:
- Limited data exist on myocardial fibrosis and inflammation in youth with HIV.
- Cardiovascular complications are a growing concern in this demographic.
Purpose of the Study:
- To assess subclinical myocardial fibrosis and inflammation in South African youth with HIV undergoing antiretroviral therapy (ART) using cardiovascular magnetic resonance (CMR).
- To compare cardiac outcomes between youth with perinatally acquired HIV (YPHIV), youth with nonperinatally acquired HIV (YNPHIV), and HIV-seronegative youth.
Main Methods:
- Cross-sectional cardiovascular magnetic resonance (CMR) imaging was performed on 464 youth (287 YPHIV, 87 YNPHIV, 90 HIV-seronegative).
- Quantile regression models assessed associations between HIV status and CMR outcomes, including late gadolinium enhancement (LGE) for fibrosis and T1/T2 mapping for inflammation.
- Key outcomes measured were LGE mass and fraction, native T1, and T2 mapping values.
Main Results:
- Youth with HIV (both YPHIV and YNPHIV) exhibited significantly higher LGE mass and LGE fraction compared to HIV-seronegative youth.
- Native T1 values were highest in the YNPHIV group, suggesting potential differences in myocardial tissue characteristics.
- CMR outcomes were comparable between YPHIV and YNPHIV, indicating similar levels of subclinical fibrosis despite different acquisition routes of HIV.
Conclusions:
- Despite ART, youth with HIV demonstrate increased subclinical myocardial fibrosis compared to their HIV-seronegative peers.
- These findings suggest that youth with HIV may benefit from early screening and monitoring for cardiovascular disease.
- The study underscores the importance of addressing long-term cardiovascular health in young individuals living with HIV.
Background:
Few data exist on myocardial fibrosis and inflammation in youth with HIV.
Methods:
We performed cardiovascular magnetic resonance (CMR) on a cross section of South African youth: youth with perinatally acquired HIV (YPHIV) undergoing antiretroviral therapy (ART), youth with nonperinatally acquired HIV (YNPHIV) receiving ART, and youth without HIV. Quantile regression models were fit to assess the association between HIV status and CMR outcomes: subclinical fibrosis (late gadolinium enhancement [LGE] mass and fraction, native T1, extracellular volume) and inflammation (native T1, T2 mapping).
Results:
Of 464 youth, 287 were YPHIV, 87 were YNPHIV, and 90 were HIV seronegative. The median age was 16 years (range, 11-24). LGE mass was higher in YPHIV and YNPHIV than in youth who were HIV seronegative (1.85 vs 2.00 vs 1.41 g, respectively), as was fraction (5.8% vs 6.4% vs 4.5%); native T1 was highest in YNPHIV. In adjusted analyses, when compared with youth with HIV seronegativity, YPHIV and YNPHIV exhibited higher LGE mass (β = 0.468, P = .001; β = 0.544, P = .002) and LGE fraction (β = 1.587, P < .001; β = 1.781, P < .001). CMR outcomes were similar between YPHIV and YNPHIV.
Conclusions:
Despite ART use, YPHIV and YNPHIV appear to have higher subclinical myocardial fibrosis than youth who are HIV seronegative and healthy adults in South Africa and may benefit from early screening/monitoring for cardiovascular disease.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction